Moreover, this study highlighted PTEN, a well-known tumour suppressor gene (TSG) [48], which supports the viability of ovarian cancer cells, as illustrated by the potential to use this tumour suppressor miRNA to target PTEN, providing further insight into miR-101 as a potential therapeutic target for ovarian cancer [47]. The gene discussed is PTEN; the disease is neoplasm.